Predicine was founded in Silicon Valley, California in 2015. Focusing on the next generation liquid biopsy diagnostic technique, we establish an integrated "one-stop-shop" biomarker service platform, and conduct big data analysis to enable precision medicine in personalized cancer care and global drug development.
Our founders are international experts in cancer research and drug development. Educated and trained in both China and the United States, we are enthusiastically devoted to address the rising and urgent healthcare needs in today's global drug development.
The makeup of Predicine is a group of industry veterans with hands-on experience, broad knowledge and domain expertise in non-invasive diagnostics, cancer immunotherapy, clinical drug development, diagnostic assay development, next-generation sequencing, bioinformatics, big data analysis, and cloud computing.
Predicine Inc has not listed any services.
Predicine offers first- and best-in-class ctRNA+ctDNA liquid biopsy assay service, for translational study and clinical trial science.
Predicine offers first- and best-in-class ctRNA+ctDNA liquid biopsy assay service, for translational study and clinical trial science.« Show less
Be the first to endorse Predicine IncEndorse this lab